Cardiology
Caring for patients with metabolic syndrome
A precursor to serious complications, this dangerous condition is on the rise among Americans.
Benefits of exercise training in heart failure
Exercise training reduces the risk for subsequent all-cause mortality or all-cause hospitalization in women by 26%, compared with 10% in men, according to a…
FDA approves Impavido to treat leishmaniasis
On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.
Study: Gestational diabetes may increase risk for atherosclerosis later in midlife
Pregnant women who develop gestational diabetes may be at risk for early atherosclerosis during midlife before the onset of diabetes and metabolic diseases, according…
Study: U.S. women don’t know most stroke warning signs
According to a study in Stroke, many U.S. women don’t know most of the warning signs of stroke. Of the 1,205 women in the…
Study: Fatigue common in CHD
A study in Nursing Research found that 40% of patients with stable coronary heart disease (CHD) reported fatigue more than 3 days a week…
Can teach-back reduce hospital readmissions?
A study shows this method helps educators focus on topics the patient doesn’t fully grasp.
MARS®: The new frontier in treating acute liver failure
A type of dialysis, MARS removes toxins and replaces lost liver functions.
6 surprising best resuscitation practices
Nothing is more important to the patient’s outcome than properly performed chest compressions.
FDA approves Omontys for anemia in dialysis patients
On March 29, the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) to treat anemia in adult patients who had chronic kidney disease…
Continuing use of statins may reduce risk of delirium in ICU patients
Continuing statin therapy in patients already on this therapy is associated with a lower daily risk of delirium in ICU patients, according to a…
Caring for patients with metabolic syndrome
A precursor to serious complications, this dangerous condition is on the rise among Americans.
Benefits of exercise training in heart failure
Exercise training reduces the risk for subsequent all-cause mortality or all-cause hospitalization in women by 26%, compared with 10% in men, according…
FDA approves Impavido to treat leishmaniasis
On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.
Study: Gestational diabetes may increase risk for atherosclerosis later in midlife
Pregnant women who develop gestational diabetes may be at risk for early atherosclerosis during midlife before the onset of diabetes and metabolic…
Study: U.S. women don’t know most stroke warning signs
According to a study in Stroke, many U.S. women don’t know most of the warning signs of stroke. Of the 1,205 women…
Study: Fatigue common in CHD
A study in Nursing Research found that 40% of patients with stable coronary heart disease (CHD) reported fatigue more than 3 days…
Can teach-back reduce hospital readmissions?
A study shows this method helps educators focus on topics the patient doesn’t fully grasp.
MARS®: The new frontier in treating acute liver failure
A type of dialysis, MARS removes toxins and replaces lost liver functions.
6 surprising best resuscitation practices
Nothing is more important to the patient’s outcome than properly performed chest compressions.
FDA approves Omontys for anemia in dialysis patients
On March 29, the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) to treat anemia in adult patients who had chronic…
Continuing use of statins may reduce risk of delirium in ICU patients
Continuing statin therapy in patients already on this therapy is associated with a lower daily risk of delirium in ICU patients, according…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.